LAZ News 50.29 05/30/2014 05:10:49 Lazard Ltd (LAZ)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lazard Ltd (LAZ) 50.29 $LAZ

2014 Value Investor 500: The Full List
Dan Dzombak, The Motley Fool - Motley Fool - Sat May 24, 8:01AM CDT
The Value Investor 500 is my attempt to highlight the top 500 publicly traded companies in the U.S. To construct a quality-based list of the top 500 companies in the U.S., I focused on what's really important for investors to pay attention to: ...

Lorillard & Reynolds American Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 22, 11:00AM CDT
Shares of cigarette manufacturers Lorillard Inc. (LO) and Reynolds American Inc. (RAI) reached 52-week highs on May 21 after media reports stated that Reynolds American is in advanced talks to take over its rival Lorillard.

Lazard Global Total Return and Income Fund Declares Monthly Distribution
Business Wire - Mon May 19, 2:54PM CDT
The Board of Directors of Lazard Global Total Return and Income Fund, Inc. (the "Fund" (NYSE:LGI) has authorized the Fund to declare today, pursuant to a level distribution policy, a monthly distribution of $0.10386 per share on the Fund's outstanding common stock. The distribution is payable on June 23, 2014 to shareholders of record on June 12, 2014. The ex-dividend date is June 10, 2014.

Post Earnings Update: Lazard Has Climbed 0.1% Higher in Past 2 Weeks (LAZ)
Comtex SmarTrend(R) - Mon May 19, 11:27AM CDT
When Lazard (NYSE:LAZ) reported earnings 18 days ago on May 1st, 2014, analysts, on average, expected the company to report earnings of $0.54 on sales of $513.5 million. Lazard actually reported earnings of $0.61 per share on sales of $549.4 million, beating EPS estimates by $0.07 and beating revenue estimates by $35.8 million. Shares of Lazard have climbed from $48.99 to $49.02, representing a gain of 0.1% since the company reported earnings 18 days ago.

Appointments, Dividends, and Quarterly Financial Results - Analyst Notes on MGIC, Validus, Lazard, Aspen and Resource Capital
PR Newswire - Fri May 16, 6:50AM CDT
Today, Analysts Review released its analysts' notes regarding MGIC Investment Corp. (NYSE: MTG), Validus Holdings, Ltd. (NYSE: VR), Lazard Ltd. (NYSE: LAZ), Aspen Insurance Holdings Ltd. (NYSE: AHL) and Resource Capital Corp. (NYSE: RSO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2556-100free.

Insider Trading Alert - UBNT, LAZ And FFIV Traded By Insiders
at The Street - Thu May 15, 11:03AM CDT
Stocks with insider trader activity include UBNT, LAZ and FFIV

Lazard Asset Management Launches First Liquid Alternative Equity Fund
Business Wire - Tue May 13, 8:02AM CDT
Lazard Asset Management LLC (LAM) today announced the launch of its first US-based open-end liquid alternative equity fund, the Lazard Fundamental Long/Short Portfolio (NASDAQ: Institutional: LLSIX; Open: LLSOX).

Lazard Asset Management Launches Emerging Markets Income Fund
Business Wire - Tue May 13, 8:02AM CDT
Lazard Asset Management LLC (LAM) today announced the launch of the Lazard Emerging Markets Income Portfolio (NASDAQ: Institutional: LEIIX; Open: LEIOX).

Technical Coverage on Financial Sector Stocks -- Research on Lazard, Portfolio Recovery Associates, Royal Bank of Scotland, and Extra Space Storage
PR Newswire - Tue May 13, 7:00AM CDT
The U.S. markets on Monday, May 12, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,695.47, up 0.68% and the NASDAQ Composite closed at 4,143.86, up 1.77%. The S&P 500 finished the session 0.97% higher at 1,896.65. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day at 298.14, up 1.04%, with the index advancing 3.94% in the last one month. Investor-Edge has initiated coverage on the following equities: Lazard Ltd (NYSE: LAZ), Portfolio Recovery Associates Inc. (NASDAQ: PRAA), Royal Bank of Scotland Group PLC (NYSE: RBS) and Extra Space Storage Inc. (NYSE: EXR). Free technical research on LAZ, PRAA, RBS and EXR can be downloaded upon signing up at:

Late-Stage Breakouts Mark Stock Spotlight
at Investor's Business Daily - Fri May 02, 4:18PM CDT
Two Stock Spotlight stocks are breaking out of bases and a third appears to be shaping a base. But all three are late-stage structures that carry extra risk, especially when the market is in a correction, as it now is. Trinity Industries (TRN) poked...

Company News for May 02, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri May 02, 9:06AM CDT
Companies in the News are: MSI,AVP,LAZ,KMT

Look for Shares of Lazard to Potentially Pullback after Yesterday's 4.12% Rise
Comtex SmarTrend(R) - Thu May 01, 4:32PM CDT
Lazard (NYSE:LAZ) traded in a range yesterday that spanned from a low of $47.11 to a high of $49.85. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $47.62 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Lazard Earnings Beat Ests, Revs Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 3:20PM CDT
Driven by top-line growth, Lazard Ltd.'s (LAZ) first-quarter 2014 adjusted earnings came in at 61 cents per share, easily beating the Zacks Consensus Estimate of 55 cents. Moreover, this compares favorably with 28 cents earned in the prior-year quarter.

Lazard Ltd Reports First-Quarter 2014 Results
Business Wire - Thu May 01, 6:03AM CDT
Lazard Ltd (NYSE:LAZ):

Another Dividend Hike at Legg Mason - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 3:40PM CDT
Continuing with the trend of increasing dividend annually since 2010, global asset management firm Legg Mason Inc. (LM) declared a 23.1% hike in its quarterly cash dividend to 16 cents per share.

Will Invesco (IVZ) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 3:10PM CDT
Invesco Ltd. (IVZ) is scheduled to report first-quarter 2014 results on Thursday, May 1, before the opening bell.

Lazard Declares Quarterly Dividend
Business Wire - Wed Apr 30, 8:02AM CDT
Lazard Ltd (NYSE:LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.30 per share on its outstanding Class A common stock. The dividend is payable on May 23, 2014, to stockholders of record on May 12, 2014.

Is CME Group (CME) Poised to Beat Earnings Ests? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 5:35PM CDT
Let's see how things are shaping up for CME Group Inc. (CME) before its earnings release on May 1.

Will MasterCard (MA) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 5:20PM CDT
Let's see how things are shaping up for MasterCard Inc. (MA) right before its earnings release on May 1.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 77

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 32

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Unusual Options Activity Signals Opportunity in GOOGL

Updated Category News Views 97

Analyzing Recent Options Activity for Alphabet Currently, investors are exhibiting a strong bullish sentiment towards Alphabet (NASDAQ: GOOGL), a trend that is capturing the attention of market participants. Recent observations of public options have revealed significant movements in GOOGL, hinting at potential changes ahead. Recent analyses have uncovered 129 unusual...

Continue Reading
Encore and UKG Introduce Innovative Overtime Savings Program

Updated Category News Views 298

Encore and UKG Join Forces for Employee Financial Wellness Encore, a prominent global leader in event technology and production services, has unveiled an innovative ‘Overtime Savings Program’ in collaboration with UKG, a top provider of HR and workforce management solutions. This remarkable initiative aims to empower Encore's frontline workers, allowing them to save...

Continue Reading
Discover Incredible Returns from Texas Pacific Land Investments

Updated Category News Views 160

The Incredible Growth of Texas Pacific Land Corp Texas Pacific Land Corp (NYSE: TPL) has marked its presence in the market with an outstanding performance over the past 15 years. The company has outshone the market median by an impressive 32.71% annually, which translates to a staggering average annual return of 45.46%. With a current market capitalization nearing $20.51...

Continue Reading
Cypherpunk Q2 2026: Zcash Growth Sparks Market Buzz

Updated Category News Views 76

Cypherpunk Technologies' Stellar Q2 Performance Sit tight, folks, because Cypherpunk Technologies just unleashed a financial update that's got the market buzzing. They've reported a staggering net income of $39.4 million for Q2 2026, quite the turnaround from a $16.6 million loss in the same quarter last year. It's a serious win, no doubt pumped up by their fruitful Zcash...

Continue Reading
Exciting Findings from Aicuris’ Clinical Trials of AIC468

Updated Category News Views 182

Encouraging Insights into AIC468 from Clinical Trials Recently, a notable advancement in medical research has emerged from Aicuris Anti-infective Cures AG regarding its novel treatment, AIC468. This drug is an innovative antisense oligonucleotide targeting the BK virus, particularly in kidney transplant recipients. The first-in-human (FIH) Phase 1 trial has provided...

Continue Reading